EXCLUSIVE: Disney Entertainment Television has chosen its participants for the 2025-26 Directing and Writing Programs, talent development initiatives which connect emerging writers and directors with ...

Java ranked third in the Tiobe Index for January 2026 at 8.71%, holding steady behind Python and C and just ahead of C++. Tiobe named C# its Programming Language of the Year for 2025 after the largest ...

Property taxes are due in counties around Oregon this month and the annual bills can run several thousand dollars. That’s a heavy lift, particularly for people on a fixed income, and taxes can make it ...

ChatGPT can help with many things—creating images, looking up information, role-playing, solving math problems, programming and much more. But at the heart of everything it does are so-called “large ...

Learn how to cast beautiful cement pots using eclipse plastic molds in this step-by-step DIY tutorial. Discover the process, tips, and tricks to create unique garden décor with ease. Perfect for ...

The Eclipse IDE is remarkably simple to install on a Windows 10 or 11 computer. To install Eclipse on Windows, simply follow the five steps outlined in this video: Download the Eclipse IDE zip file ...

President Donald Trump’s Mar-a-Lago Club was approved for up to 170 temporary foreign worker H-2B visas this fiscal year, the most in the past decade, records show. H-2B visas form part of the ...

OKLAHOMA CITY (KFOR) – Artificial intelligence is reportedly making its way into a traditional Medicare pilot program that six states, including Oklahoma, will test out. It has to do with patients ...

On Friday afternoon, writers who applied for the National Endowment for the Arts’ 2026 Creative Writing Fellowships received an email from the NEA saying that the program had been canceled. The annual ...

Elevate your grant writing to craft compelling proposals and secure research funding. The Grant Writing Intensive (GRIT) program is a year-long practicum designed to empower faculty from the CCTS ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the ...

Opinions expressed by Mashable Perspectives contributors are their own and are separate from Mashable's editorial team. If you buy a product featured here, we may earn a commission. Credit: Mashable ...